| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b840f99bcb977127644a7ea826496a8b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
| filingDate |
1981-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1986-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bfcd301fed57497d81120614f79c37f |
| publicationDate |
1986-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4590210-A |
| titleOfInvention |
Compositions for treatment of ocular hypertension |
| abstract |
Compositions for treating ocular hypertension by topical administration containing α-methyl epinephrine, α-methyl norepinephrine, their C 1 -C 8 alkanoyl diesters and the pharmacologically acceptable acid addition salts thereof are disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5306731-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012101167-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003216413-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10993921-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5863948-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012060860-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11045432-B2 |
| priorityDate |
1979-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |